Last updated on March 2019

A Study in Adult Patients With Type I III or IV Osteogenesis Imperfecta Treated With BPS804

Brief description of study

The purpose of this study is to select a suitable dose of BPS804 by measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 12 months and followed up for a further 12 months.

Clinical Study Identifier: NCT03118570

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.